Hemera Biosciences

Hemera Biosciences is a company that uses gene therapy as a one-time treatment in patients with age-related macular degeneration (AMD). It develops HMR59, a drug that is injected in the eye, increasing the ability of retina cells to make a soluble form of the protective protein CD59.